Aspiriant LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$274K Buy
2025
Q2
$337K Sell
2025
Q1
$365K Buy
2024
Q4
$449K Sell
2024
Q3
$641K Sell
2024
Q2
$856K Buy
2024
Q1
$617K Sell
2023
Q4
$537K Sell
2023
Q3
$475K Hold
2023
Q2
$423K Hold
2023
Q1
$416K Buy
2022
Q4
$205K Buy
2017
Q2
Sell
2017
Q1
$280K Buy